To reach the brain from peripheral sites, prions must colonize various cell types within the lymphoreticular compartment. However, no prion entry receptors are yet known. Toll-like receptors (TLRs) are pattern-recognition receptors that bind a multitude of pathogens and are therefore candidates as effectors of prion entry. Moreover, injection of unmethylated CpG oligodinucleotides, which stimulate TLR9, has been reported to delay peripherally initiated scrapie. We therefore studied prion infection in MyD88(-/-) mice, which are defective in TLR signalling. Despite subtle defects in splenic microarchitecture, MyD88(-/-) mice challenged intraperitoneally or intracerebrally were fully susceptible to disease and died of scrapie after similar incubation times to those of wild-type mice. Splenic infectivity titres rose to similar levels with the same kinetics, and brains showed similar histopathological changes. TLR signalling therefore does not have any major role in prion pathogenesis, and the protective effect of TLR stimulation is unlikely to result from direct interactions with prions. −/− mice challenged intraperitoneally or intracerebrally were fully susceptible to disease and died of scrapie after similar incubation times to those of wild-type mice. Splenic infectivity titres rose to similar levels with the same kinetics, and brains showed similar histopathological changes. TLR signalling therefore does not have any major role in prion pathogenesis, and the protective effect of TLR stimulation is unlikely to result from direct interactions with prions.
INTRODUCTION
Host organisms detect infection by recognizing pathogen-associated molecular patterns that induce innate responses to infections. Tolllike receptors (TLRs) are crucial mediators of such responses. Toll is crucial in antifungal immunity of Drosophila (Lemaitre et al., 1996) . TLRs are mammalian Toll homologues expressed by immune cells. At least 10 members of the TLR family exist. At present, ligands have been identified for TLR1 to TLR9. Most of these ligands are derived from pathogens and comprise a heterogeneous group, including viruses, bacteria, DNA, RNA, toxins and chemical compounds. TLR9 is required for immune responses triggered by bacterial DNA (Hemmi et al., 2000) . MyD88 is a cytoplasmic adapter protein that associates as an obligate functional partner with all members of the TLR and interleukin-1 receptor (IL-1R) family (Muzio et al., 1997; Medzhitov et al., 1998) . MyD88 −/− mice do not show any response to IL-1 family cytokines in vivo (Adachi et al., 1998) , are resistant to lipopolysaccharide-induced endotoxin shock syndrome (Kawai et al., 1999) , and fail to respond to peptidoglycans and lipoproteins (Takeuchi et al., 2000) , antiviral compounds (Hemmi et al., 2002) , CpG DNA (Hacker et al., 2000) and flagellins (Hayashi et al., 2001) . In prion diseases, the immune system exerts a crucial role during the early extracerebral phase that follows peripheral administration of the agent ). B cells (Klein et al., 1997) , follicular dendritic cells (FDCs) (Montrasio et al., 2000) and other haematopoietic and stromal cells in spleen and lymph nodes Prinz et al., 2002) are involved in the process of peripheral uptake, amplification and probably transport of prion infectivity. However, the receptors used by invading prions to enter host cells are unknown. FDCs trap opsonized antigens on their surface with Fcγ and complement receptors, and mice lacking opsonins or complement receptors are partly protected against the intraperitoneal administration of prions Mabbott et al., 2001) . However, complement is evidently not the only system involved, because complement-deficient mice succumb to scrapie after peripheral challenge with high doses of scrapie inoculum .
A recent study has shown that the injection of CpG oligodeoxynucleotides, which stimulate the innate immune system via the TLR9 receptor, provides partial protection against prions administered intraperitoneally (Sethi et al., 2002) . The mechanism underlying this spectacular finding might be indirect: stimulation of TLR9-expressing immune cells might trigger a constellation of cytokines and other mediators that eventually results in an environment unfavourable for prion replication. Alternatively, prions might conceivably bind and/or signal through TLRs-a process that could be competed for by 'therapeutic' TLR ligands. Here we investigated a possible direct role of TLR-mediated responses in peripheral and central prion pathogenesis by administering prions peripherally or intracerebrally to mice lacking the cytoplasmic adapter protein MyD88, which is the central transducer of TLR and IL-1R signalling.
RESULTS

Germinal centres and FDCs in MyD88
−/− mice To judge the extent to which the absence of MyD88 affects the morphology of germinal centres, we examined spleens with immunohistochemical stains for B cells, FDCs and complement receptor 1 (Fig. 1) . In wild-type littermates from MyD88 +/− intercrosses, which served as control mice, normal shape of the follicles and segregation of distinct B-and T-cell zones were apparent on spleen sections (Kosco et al., 1992) and of tingible-body macrophages (Kosco-Vilbois, 2000) (Fig. 1 ). CD35-positive FDC networks were also conspicuous in wild-type and MyD88 −/− mice. −/− mice occasionally seemed oddly-shaped and slightly disorganized when compared with those of wild-type mice (data not shown).
MyD88
−/− mice are highly susceptible to scrapie
Mice deficient for MyD88 were challenged with various quantities of prions, and the incubation time to terminal disease was measured. After intracerebral injection with a high dose (3 × 10 5 LD 50 ) or a low dose (3 × 10 2 LD 50 ) of Rocky Mountain Laboratory scrapie strain (RML), all treated MyD88 −/− and wild-type mice reached terminal disease with similar incubation times ( Table 1 ). In both genotypes, terminal illness was correlated with typical clinical signs of scrapie such as ataxia, kyphosis, hind leg paresis and, in males, priapism. These results clearly demonstrate that MyD88 −/− mice are highly susceptible to cerebral prion infection.
After high-dose intraperitoneal prion challenge (6 logLD 50 ),
−/− and wild-type mice developed scrapie with similar incubation times of between 197 and 207 days (Table 1) , indicative of unaffected peripheral prion pathogenesis and neuroinvasion. The mean incubation time after administration of a 1,000-fold diluted inoculum (3 logLD 50 ) to MyD88 −/− mice was slightly longer (Table 1) . Five MyD88 −/− mice died between 213 and 261 days after injection, which was superimposable on the incubation range of wild-type mice. However, two mice had longer incubation times (270 and 274 days after injection), resulting in a larger standard deviation within this group. A Student's t-test yielded P > 0.05, indicating that the incubation times in the two groups were not significantly different. Importantly, all of these seven peripherally challenged MyD88 −/− mice developed scrapie after administration of a low-dose inoculum, indicating that MyD88 is dispensable for peripheral prion pathogenesis.
Immunoblot analysis confirmed PrP Sc accumulation in the brains and spleens of terminally ill MyD88 −/− mice (Fig. 2) . Accordingly, haematoxylin/eosin stains and glial fibrillary acidic protein (GFAP) immunohistochemistry of terminally ill mice lacking MyD88 and of wild-type mice showed similar patterns of vacuolization and of reactive astrogliosis within the hippocampal ribbon (Fig. 3) . Brain pathology during prion disease was therefore also unaltered in MyD88 −/− mice.
Prion replication in MyD88 -/-mice
We then determined prion infectivity over time in spleens of mice inoculated intraperitoneally (6 logLD 50 ). Infectivity was determined by transmission of homogenized tissues into tga20 indicator mice (Fischer et al., 1996) and comparison of incubation times against a calibration curve. Infectivity in spleens of MyD88 −/− (Fig. 4 , red circles) and wild-type (blue circles) mice after intraperitoneal infection was generally similar in mice of both genotypes. In addition, the time courses of the process by which prion invaded the spleen were clearly similar: a considerable amount of infectivity was already present at 35 days after injection in the spleen of both groups. Further measurements at 90 and 120 days after inoculation confirmed that the levels of prion infectivity in wild-type and MyD88 −/− mice were always very similar. A lack of MyD88 therefore does not impair the rate and kinetics of lymphoreticular prion invasion after intraperitoneal administration. 
DISCUSSION
The innate immune system is the first line of defence against infection. The most important sensors for the recognition of these invading microorganisms are the TLRs. Activation of the innate immune system by CpG oligodeoxynucleotides has been shown to prevent prion disease in mice (Sethi et al., 2002) . This observation is surprising because activation of the immune system was thought to enhance, rather than protect from, peripheral prion disease. Protection might be due to TLR9-mediated immune activation or to direct competition of PrP Sc with TLRs. PrP Sc is highly aggregated and forms ordered molecular arrays (Wille et al., 2002) of congophilic, anisotropic amyloid with predominant β-sheet conformation. These characteristics led us to propose that canonical pattern receptors, such as TLRs, might be involved in prion pathogenesis. However, the results presented here imply that prion replication and neuroinvasion can take place in secondary lymphoreticular organs in the absence of TLR signalling.
After intraperitoneal low-dose challenge with prions, we observed a delay of 24 days in mean incubation of MyD88 −/− in comparison with wild-type mice of the same genetic background. Statistical analysis did not reveal a significant difference between the two groups. The slight difference might be due to a subtle impairment in germinal-centre architecture of MyD88 −/− mice: this compartment is of pivotal importance in peripheral prion pathogenesis, and the observed changes might slightly affect prion pathogenesis. All other investigated parameters of pathogenesis, such as amount of PrP Sc in infected brains and spleens, kinetics and amount of infectivity in the spleens, as well as neuropathological changes of end-stage brains, were identical in MyD88 −/− and wild-type mice. The cytoplasmic portion of TLRs is similar to that of IL-1R and IL-18R. The signalling pathway via TLRs is therefore homologous to that of the IL-1R family, and both TLRs and IL-1Rs interact with MyD88. MyD88 −/− mice do not show any response to IL-1 or IL-18 (Adachi et al., 1971) . These cytokines might have a significant role in many neurodegenerative diseases (Allan & Rothwell, 2001 ). Expression of IL-1 was detected in brains of animals that were ill with scrapie (Williams et al., 1994) but another study failed to reproduce this finding (Walsh et al., 2001 ). The present study indicates that IL-1R signalling is positively needed neither for peripheral prion pathogenesis nor for the chronic neurodegeneration seen in prion disease.
Our findings are not incompatible with the reported prophylactic effect of CpG oligonucleotides in scrapie-inoculated mice (Sethi et al., 2002) but make it unlikely that stimulators of innate immunity compete with prions for a common pathway. Instead, it is more likely that strong stimulation of TLRs exerts its effects indirectly, for example by conjuring an immunological environment generally hostile to prion infection. 
MyD88 −/− and wild-type mice developed scrapie after similar incubation periods after administration of a high or a low intracerebral dose of prions. A high peritoneal prion challenge (6 logLD 50 ) also elicited scrapie with a similar latency, whereas after intraperitoneal challenges with a lower dose (3 logLD 50 ) MyD88 −/− mice developed terminal disease with a slightly longer incubation period than wild-type mice. Latency, latency of disease in individual mice. 
scientific report
Toll-like receptor signalling and scrapie M. Prinz et al. Two caveats still persist before we can conclude that TLRs do not have any role in prion diseases. First, activation of TLR4 signalling was described to occur by an alternative pathway that does not involve MyD88 (Fitzgerald et al., 2001) , and might mediate some aspects of prion pathogenesis. Second, scrapie prions might use TLRs for docking to relevant cells but fail to activate MyD88-mediated signalling. This possibility is not totally remote because prion infection does not typically elicit strong adaptive immune reactions.
The identification of the recognition receptors that are involved in prion entry, replication and accumulation in host cells therefore continues to be a priority in prion research, because it will help in our understanding of the molecular pathogenesis of prions and might even point to prophylactic or therapeutic strategies against these diseases.
METHODS
Scrapie infections. MyD88
+/− mice (Adachi et al., 1998) were interbred to obtain homozygous and wild-type C57Bl/6 mice. Animals were maintained under specific pathogen-free conditions and were infected intraperitoneally with brain homogenate in 100 µl PBS containing 6 logLD 50 or 3 logLD 50 units of the RML scrapie strain (passage 5). For intracerebral inoculations, 30 µl of inoculum with 3 × 10 5 LD 50 or 3 × 10 2 LD 50 were administered. Mice were monitored every second day, and scrapie was diagnosed by standard clinical criteria. Mice were killed on the day of onset of terminal clinical signs of scrapie. Infectivity bioassay with tga20 indicator mice. Assays were performed on 1% spleen homogenates. Tissues were homogenized in 0.32 M sucrose with a micro-homogenizer, diluted in PBS and 5% BSA, then passed several times through 18-gauge and 22-gauge needles. When the solution seemed homogenous, it was centrifuged for 5 min at 500g. Supernatants (30 µl) were inoculated intracerebrally into groups of four tga20 mice (Fischer et al., 1996) . The relationship y = 11.45 − 0.088x (y, log LD 50 per milliliter of homogenate; x, incubation time in days to terminal disease) was calculated by linear regression (Prusiner et al., 1982; Kaeser et al., 2001) . Western blot analysis. Tissue homogenates were adjusted to 8 mg ml −1 protein, then treated with proteinase K (20 µg ml −1
, 30 min, 37°C ). Total protein (50 µg) was subjected to SDS-12% polyacrylamide-gel electrophoresis. Proteins were transferred to nitrocellulose by semi-dry blotting. Membranes were blocked with Trisbuffered saline containing 0.1% Tween 20, pH 8, plus 5% non-fat milk, incubated with monoclonal antibody ICSM18 (Hill & Collinge, 2002) and detected by enhanced chemiluminescence (ECL; Amersham). Histology and immunohistochemistry. Paraffin-embedded and frozen sections from brain and spleen were stained with haematoxylin/eosin. Immunostaining for the astrocytic marker glial fibrillary acidic protein (GFAP) was performed with a rabbit antiserum against GFAP (1:300 dilution; DAKO) and detected with biotinylated pig anti-rabbit serum (1:250 dilution; DAKO) and diaminobenzidine (Sigma). The follicular dendritic cell marker FDC-M1 (clone 4C11; 1:300 dilution), the complement marker CD35 (8C12; Pharmingen) and the pan-B cell marker anti-CD45RO/B220 (RA3-6B2; Pharmingen) were used as described (Karrer et al., 2000) . Morphometric analysis was performed with Analysis Pro 3.1 software (Soft Imaging System).
